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ARTICLE
Circular DNA elements of chromosomal origin are
common in healthy human somatic tissue
Henrik Devitt Møller1, Marghoob Mohiyuddin2, Iñigo Prada-Luengo 1, M. Reza Sailani3, Jens Frey Halling1,
Peter Plomgaard4,5, Lasse Maretty1, Anders Johannes Hansen6, Michael P. Snyder3, Henriette Pilegaard1,
Hugo Y. K. Lam2 & Birgitte Regenberg 1
The human genome is generally organized into stable chromosomes, and only tumor cells are
known to accumulate kilobase (kb)-sized extrachromosomal circular DNA elements (eccD-
NAs). However, it must be expected that kb eccDNAs exist in normal cells as a result of
mutations. Here, we purify and sequence eccDNAs from muscle and blood samples from 16
healthy men, detecting ~100,000 unique eccDNA types from 16 million nuclei. Half of these
structures carry genes or gene fragments and the majority are smaller than 25 kb. Tran-
scription from eccDNAs suggests that eccDNAs reside in nuclei and recurrence of certain
eccDNAs in several individuals implies DNA circularization hotspots. Gene-rich chromo-
somes contribute to more eccDNAs per megabase and the most transcribed protein-coding
gene in muscle, TTN (titin), provides the most eccDNAs per gene. Thus, somatic genomes
are rich in chromosome-derived eccDNAs that may inﬂuence phenotypes through altered
gene copy numbers and transcription of full-length or truncated genes.
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The human genome contains 22 linear autosome pairs and apair of sex-determining chromosomes. This genomestructure was previously thought to be highly stable, with
minimal divergence between cells1,2. Genome-scale sequencing
has revealed that insertions, deletions, and ampliﬁcations are
common in humans3–5 and even single cells from healthy somatic
tissues contain large structural variations6.
However, the fate of the deleted chromosomal DNA in human
somatic cells is unknown. Deleted acentric DNA may be
removed from cells by targeted degradation or exclusion from
replication. We hypothesized that deleted DNA as well as by-
products of damaged DNA can circularize and co-exist in gen-
omes as semi-stable extrachromosomal circular DNA (eccDNA;
see Supplementary Note 1 for review of abbreviations for circular
DNA). Evidence of eccDNA in humans has existed for more
than half a century since double minutes were discovered in
tumor specimens from children7. EccDNA was later shown to be
common in many types of cancers, forming from chromosomal
genes and promoting oncogenesis8–11. In addition to oncogenes,
5 S ribosomal DNA (rDNA) and repetitive DNA have been
found on eccDNA in human cell lines12–14, showing that a
fraction of the genome can exist as eccDNA, at least under
certain conditions.
Circular DNA structures of megabase (Mb) sizes are also
known as ring chromosomes and can be visualized micro-
scopically by staining metaphase DNA15,16. Identiﬁcation of
smaller circular DNA has been by achieved by density separa-
tion of DNA by cesium-chloride ultracentrifugation, followed by
electron microscopy17. EccDNA has also been isolated using
linear DNA-speciﬁc exonucleases18,19 or targeted probes for
speciﬁc eccDNA types and imaging after two-dimensional gel
electrophoresis12 or ﬂuorescence in situ hybridization10.
Advances in sequencing technologies have allowed for genome-
scale identiﬁcation and mapping of eccDNAs that range in size
from 0.1 kilobase (kb) to 2 kb (named microDNA) from human
cell lines and mice20,21. These <2 kb eccDNAs were shown to
derive primarily from genic regions in which exons and 5’-
untranslated regions (UTRs) were particularly over-
represented20. Moreover, recent screens of blood from cancer
patients revealed that <2 kb eccDNA can also be found in
plasma22. The discovery of <2 kb eccDNAs in healthy lung tis-
sue of lung cancer patients suggest that eccDNA either migrates
from the malignant tissue or forms in the healthy tissue22. In
addition, the Wang group recently characterized eccDNAs of up
to 20 kb in blood plasma from healthy donors23. We hypothe-
size that the healthy tissue also contains larger eccDNAs of
sufﬁcient size to include one or several full-length genes, because
(1) eccDNAs larger than 100 kb are found in human
tumors9,10,24, most likely arising by random mutational pro-
cesses that would be expected to form eccDNAs from all parts of
the genome; (2) deletions are known to produce eccDNAs in
yeast25 and in cattle26; and (3) deletions in somatic cells can be
up to Mb in size6.
Here, we investigate if eccDNAs are common in somatic
tissues from healthy humans (muscle and leukocytes),
employing enzymatic removal of linear DNA and sequencing of
DNase-resistant eccDNA27,28. We detect a large catalog of
different eccDNAs formed from chromosomal breakpoints
between 0.05 kb and up to 999.8 kb apart. EccDNAs derive from
every human chromosome with sequences from all known
types of genomic structures, including genes, intergenic, and
repetitive regions, revealing that eccDNAs are common muta-
tional elements in human soma. Our discovery suggests that
products of deletions are maintained in somatic cells, leading to
novel questions regarding their cellular inﬂuence and potential
biological roles.
Results
Genome-wide detection of eccDNAs from soma in healthy
men. To obtain knowledge about eccDNAs in human soma, we
adapted the Circle-Seq method27,28, which detects eccDNAs on a
genomic scale, for human tissue (Fig. 1). EccDNAs were puriﬁed
from skeletal muscle biopsies and blood leukocytes from two
groups of healthy men (mean age 62.4 ± 2.4 years). One group (n
= 8) had exercised throughout their life (physically active) and
the second group (n= 8) had lived a lifelong sedentary lifestyle
(physically inactive, Supplementary Table 1). We chose to com-
pare these two groups of men because they have very different
lifespan expectancies29. Exercise training is reported to protect
against oxidative stress and may, therefore, reduce DNA damage,
as reported for sperm nuclear DNA from patients with var-
icocele30, which ultimately could lead to group differences in
eccDNA formation. Our biochemical data conﬁrmed that the
oxidative stress levels were signiﬁcantly higher in muscle tissue
from physically inactive men than men with an active lifestyle
(protein carbonylation, Supplementary Table 1).
Puriﬁcation, enrichment, and detection of eccDNAs from
somatic samples were performed in four steps (Fig. 1a–c): 1)
gentle DNA isolation by column separation, 2) removal of
remaining linear DNA by exonuclease, 3) rolling-circle ampliﬁca-
tion, and 4) sequencing and mapping of paired-end reads to the
human genome to identify structural variation resulting from
DNA circularization. We conﬁrmed that linear DNA was
completely removed after exonuclease treatment using quantita-
tive PCR (qPCR) on a gene absent from eccDNA as a marker
(COX5B, Supplementary Fig. 1a, b). Each detected circular DNA
structure was supported by a minimum of two independent
structural-read variants that identiﬁed the chromosomal break-
point coordinates that were joined on the eccDNA (e.g., one split-
read and one discordant-read pair, Fig. 1c). In addition, detected
eccDNAs were hierarchically ranked based on read coverage by
comparison to adjacent upstream and downstream regions. We
assigned high conﬁdence (hconf) support to eccDNAs with read
coverage >95% and more than two-fold higher mean coverage
relative to the summed coverage of adjacent regions of equivalent
lengths (Fig. 1c). EccDNAs ranked with conﬁdence (conf) had
>95% read coverage, but less than two-fold higher read coverage
relative to outside sequences, and ﬁnally, eccDNAs with coverage
<95% were annotated solely based on the structural-read variants
(low quality, lowq) (Fig. 1c, d). In total, we detected 43,960 hconf
eccDNAs, 81,066 conf eccDNAs, and 13,655 lowq eccDNAs from
muscle samples (average: 2,748 hconf, 5,067 conf, and 853 lowq
per sample of 106 nuclei). In leukocytes, we detected 6,253 hconf
eccDNAs, 3,191 conf eccDNAs, and 784 lowq eccDNAs (average:
391 hconf, 199 conf, and 49 lowq per sample of 104 nuclei)
(Supplementary Table 2). We found saturation tendency in
detection of eccDNAs relative to the number of sequenced reads,
suggesting that the majority of eccDNAs were recorded by our
analysis (Supplementary Fig. 2). Possible false-positive detection
was assessed on full-genome human sequence data, the NA12878
Platinum genome data set31. When testing the bioinformatics
pipeline on NA12878, we found 0 eccDNAs supported by split
reads (partial reads mapping to both sides of a junction) and just
54 eccDNAs (0.75 %) supported by soft-clipped reads (partial
reads mapping to one side of a junction) (Supplementary Table 2).
As 62,763 (45%) and 2,799 (27%) of all detected eccDNAs in
muscle tissue and leukocytes were supported by split reads and
53,890 (39%) and 2,325 (23%) eccDNAs were supported by soft-
clipped reads, we are conﬁdent that the majority of all detections
represented true eccDNAs (with an estimated false-positive rate
of about 0.75%). In addition, we cannot exclude that some of the
signals interpreted as false-positives in the NA12878 genome data
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set were actually derived from eccDNA in the whole-genome
data. Hence, the rate of false-positives might be lower.
As an example, 130 eccDNAs were mapped to the 0.3-Mb titin
gene, TTN (Fig. 1d). Two representative examples of TTN
eccDNAs were 24 kb and 35 kb in size, covering exons 44–52 and
43–66 (Fig. 1e). These two structures were conﬁrmed by outward
PCR and Sanger sequencing (Fig. 1e, f) and named [TTNcircle exon
43-66] and [TTNcircle exon 44-52] to indicate their genic origin and
non-Mendelian, circular character. We apply this nomenclature
to all eccDNAs. EccDNAs are also referred to by their
chromosomal origin such as [TTNcircle 179,592-179,627kb] and
[TTNcircle 179,598-179,621kb] to accommodate non-genic eccDNA
and genic eccDNA without exons (see Supplementary Note 1 for
acronyms and nomenclature).
EccDNAs are common in human soma. More than 100,000
different eccDNAs (n= 138,027) were identiﬁed from 16 muscle
samples (Supplementary Data 1, Supplementary Fig. 1c-e). All
chromosomes were represented in eccDNA sequences, which had
a combined length of 12.6% (389.5 Mb) of the human genome.
EccDNAs ranked with hconf ranged in size from 0.05 kb up to
57.8 kb with two distinctive peaks at 0.1 kb and 5 kb (Fig. 2a, b).
Structures ranked with lower support derived from breakpoints in
chromosomes up to 887.9 kb (conf) or 999.8 kb (lowq) apart
(Supplementary Data 1), suggesting existence of eccDNAs up to
1Mb. Although there were individual variations within and
between muscle samples from the two groups, the frequency of all
eccDNA types showed no signiﬁcant differences between physi-
cally active (median 8,469 different eccDNAs/106 nuclei, range
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Fig. 1 Circle-Seq method for mapping of eccDNA. a Leukocyte and muscle samples from 16 healthy subjects (T1–T16, n= 16). b Puriﬁcation of eccDNA
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464–19,702) and inactive men (median 9,255 different eccDNA/
106 nuclei, range 3,425–14,498) based on a Wilcoxon rank sum
test (p-value= 0.95, 95% conf interval, [−7,137; 6,074]). Never-
theless, given the wide conf interval, signiﬁcant differences
between eccDNA counts from inactive and active men might
have been missed with the current sample size (Fig. 2a, b).
EccDNA from the 16 leukocyte samples, each from ~104 nuclei
(Supplementary Fig. 1f), showed comparable eccDNA frequencies
and size distributions (Supplementary Fig. 3a, b, Supplementary
Data 2) between physically active (median 356, range 284–919)
and inactive men (median 528, range 218–2,347) with no sig-
niﬁcant differences based on Wilcoxon rank sum tests (p-value=
0.43, 95% conf interval, [−783; 136]). When comparing eccDNA
frequencies from both types of examined soma, we detected
3.5–5.6 different eccDNAs per 100 nuclei of leukocytes compared
to 0.85–0.93 different eccDNAs per 100 nuclei in muscle tissue.
The sensitivity of Circle-Seq was measured using internal
plasmid controls added to muscle and blood samples prior to
eccDNA puriﬁcation. Plasmids were recaptured in all samples
supporting a detection level of one plasmid per 10,000 nuclei
(pSH63, 7 kb, Fig. 2c and Supplementary Fig. 3c). Plasmids larger
than 10 kb were also detected, although with fewer mapped reads
(e.g., 26-kb YGMP3k20, Fig. 2c). Using plasmid controls, we
estimated that Circle-Seq detected ~1–250 eccDNAs per nucleus
in the 4-kb range and detected eccDNAs with short interspersed
nuclear elements (SINEs) in a broad range of 16–1700 per
nucleus. This result is in line with previous reports on HeLa cells
with 1600 microDNAs per nucleus in sizes smaller than 400 bp20
and 50–200 eccDNAs per cell (ref. 32 for review).
A large fraction of eccDNA reads map to repetitive regions.
Repetitive satellite elements32 and 5 S rDNA12 are known to form
eccDNAs in human cells. Moreover, repetitive telomeric circles
can lead to human cell immortalization through telomerase-
independent elongation of telomeres33,34. We found that 0.8% of
reads mapped to telomeres, suggesting that [TELcircles] are also
present in healthy benign tissue. A substantial number of reads
also mapped to SINEs (3.1%), long interspersed nuclear elements
(LINEs) (3.5%), retroviruses (1.4%), satellites (1.2%), centromeres
(2.0%), long terminal repeat (LTR) retrotransposons (0.3%), and
rDNA repeats (8.1%) (Fig. 2d; blood Supplementary Fig. 3d),
supporting the existence of eccDNAs from all tested types of
repetitive elements in the human genome.
Genic eccDNAs are common. The majority of eccDNAs (99%)
were smaller than 25 kb (Fig. 2a, b, Fig. 3a, Supplementary Fig. 3a,
b; Supplementary Fig. 4), while the remaining 1% derived from
breakpoints more than 25 kb apart (Fig. 3b). More than half of all
eccDNAs came from genic or pseudogenic regions (blood 55%,
tissue 52%). For example, the 11.1-kb [S100A3-S100A4circle
153,512-153,523kb] in sample T8 included the complete genes of
S100A3 and S100A4 and parts of S100A5. S100A4 encodes a
protein known to have a causal role in the metastatic spread of
tumor cells35.
Veriﬁcation of eccDNAs as large as 35 kb. We veriﬁed 85% of all
tested eccDNAs (17 out of 20) by Sanger sequencing of outward
PCR products (Fig. 4a, Fig. 1d, f, Supplementary Fig. 4, Supple-
mentary Table 3). Tested unique eccDNAs came both from
intergenic and genic loci. For instance, we conﬁrmed the
[ERBB2circle exon 1-7], which included the ﬁrst seven introns and
exons of ERBB2 (Fig. 4a). This gene encodes the human epi-
dermal growth factor receptor 2 that is associated with cancer
when deleted or ampliﬁed8,36,37.
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Deletions correspond to eccDNA. The discovery of [ERBB2circle
exon 1-7] and other eccDNAs with parts of genes suggested that
these entities could contribute to the generation of truncated
chromosomal and extrachromosomal genes. In one case, we
conﬁrmed that a muscle-derived eccDNA also showed evidence
of a chromosomal deletion. At the DAZ4 gene, a DNA deletion
was found at the precise site where the [DAZ4circle exon 18] formed
(Fig. 4b, c). We also detected eccDNAs from loci reported to
frequently undergo gross DNA deletions, such as HLA (5 Mb,
6p21.32–p22.1), KIR (1 Mb, 19q13.42), and SERF1A_SMN2 (2.5
Mb, 5q13.2)38,39 in both blood and muscle (Fig. 3b; Supple-
mentary Data 3). These ﬁndings indicated that large deletions can
lead to eccDNA in healthy human soma.
Recurrent breakpoints ﬂank full-length genes. More than 1000
conf and lowq eccDNAs were derived from chromosomal
breakpoints that were more than 25 kb apart (Fig. 3b). With an
average gene size of 27 kb in the human genome40 many of these
potential eccDNAs could be large enough to contain full genes.
The majority of breakpoints >25 kb apart ﬂanked genic loci
(74%), and the largest was [PRRC2B-SETXcircle 134213-135213kb] at
1 Mb (Supplementary Data 3). Notably, several breakpoints >25
kb apart from nearly identical genic or intergenic regions were
found in two or more individuals (Fig. 3b). For instance, the 941-
kb [HLA-E_HLA-Ccircle 30,372-31,314kb] came from precursor genes
of the major histocompatibility complex (class I, E, and C) and
was identiﬁed in participants B6 and B14. [SERF1A_SMN2 circle
68,904-69,760kb] was detected by junction reads that mapped to two
identical noncoding RNA genes, 838 kb apart, in participants B3,
B5, and B9 (Fig. 3b and Supplementary Data 4). Recurrent
eccDNAs are known in yeast, where paralogous genes and
repetitive sequences recombine to form identical eccDNAs in
independent cell lines25,27,41. This phenomenon also appeared to
occur in humans as breakpoints in blocks of paralogous genes
were found repeatedly in two or more participants. For instance,
we found recurrent breakpoints >25 kb apart that ﬂanked genes
in the preferentially expressed antigen in melanoma family
(PRAMEF), the histone cluster 2, defensin betas, the C-C motif
chemokine ligands, and killer cell immunoglobulin-like receptors
(Fig. 3b and Supplementary Data 3 and 4). Although the potential
large eccDNAs had fewer sequence reads assigned to them, the
joint probability of ﬁnding similar breakpoints by chance in two
participants is <10−12, using an overlap of 95%. These results
suggested that chromosomal breakpoints in loci up to several
100,000 bp apart could lead to eccDNA and some loci were
hotspots for DNA circularization.
Co-occurrence between eccDNAs and structural variants. We
further tested the co-occurrence between coordinates of common
structural variants in the human genome42 and eccDNA break-
points >25 kb apart. We found 22 hits with a reciprocal overlap of
99%. The hits included, among others, common deletions of
genes from PRAMEF14/15/17/19/20 (220 kb, 1p36.21), DNAH14
(115 kb, 1q42.12), PSG4/5/9/10 (191 kb, 19q13.31), as well as
repeats from satellites (1p11.2 and 5q11.1) and regions with
LINE/SINE/LTR elements (131 kb, 1q12-1q21.1; 35 kb, 15q11.2).
We also detected overlap between the 54-kb [APOL1_A-
POL4circle] and a common inversion of the same apolipoprotein
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genes. Missense variants of the APOL1 gene are reported to be
associated with a 15% increased risk of kidney disease43. Finally, a
common deletion of the immunoglobulin heavy chain variable
region (281 kb, 22q12.3) overlapped an eccDNA detected in
sample T6: [abPartscircle chr2: 89,161,023-89,441,956].
Highest frequency of eccDNAs from gene-rich chromosomes.
The genomic distribution of eccDNAs revealed that the gene-rich
chromosomes 17 and 19 contributed to a, respective, 1.7-fold and
2.9-fold higher average frequency of eccDNAs per Mb than other
chromosomes (Fig. 5a, Supplementary Fig. 5a). We found positive
correlation between the ratios of eccDNA/Mb and coding genes/
Mb (Fig. 5b, Supplementary Fig. 5b, ρ= 0.78), while pseudogenes,
short variants, and long, short, or miscellaneous types of non-
coding genes correlated less well with eccDNA frequency (ρ ≤
0.69, Supplementary Fig. 5c-g). This result suggested that tran-
scription or other characteristics of coding genes affected the
frequency of eccDNA formation. We measured the global mRNA
level in all obtained muscle samples to examine whether tran-
scription could explain eccDNA frequencies. Although some of
the most highly expressed genes gave rise to many eccDNAs, in
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particular the TTN-AS1 and TTN genes of the physically active
group, with >100 eccDNAs (Fig. 5c, Supplementary Data 5), we
found no general correlation between the numbers of eccDNAs
per gene and transcript level.
Transcription of eccDNA. To investigate whether eccDNAs
were transcribed, we screened mRNA sequences from muscle
tissue that could match transcription events across the junction
of detected eccDNA. We identiﬁed junction transcripts from 25
different eccDNAs in muscle samples from eight participants
(Supplementary Table 4, p < 0.001, Monte Carlo simulation).
The sampled eccDNA transcripts conﬁrmed the existence of
eccDNA. For example, in ﬁve participants, we detected split-
transcript reads from the TTN gene that matched detected
[TTNcircle] coordinates, one of which had a detected size of
612,228 bp. We detected, with hconf, a perfect overlap between
eccDNA coordinates of the 18-kb [HIP1circle exon 1] in participant
8 (T8) and mRNA transcription of the ﬁrst exon of Huntington-
interacting protein 1 from T8 (Fig. 6). The transcript data sug-
gested that at least a fraction of the eccDNAs was present in
nuclei and not sequestered in transcriptionally inactive com-
partments of the tissue. The eccDNA transcripts further exclu-
ded the possibility that detected eccDNAs were merely by-
products of apoptosis-driven fragmentation, as suggested for <2-
kb eccDNA (microDNA)44, or were produced during eccDNA
puriﬁcation.
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Fig. 6 EccDNA transcript from the [HIP1circle exon 1]. Display of chromosome 7 at the HIP1 gene and detected [HIP1circle exon 1]. The two sequenced RNA reads
(black and orange text) from participant T8 overlap perfectly to the two sequenced DNA reads from participant T8 (black and bold text font)
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EccDNA variation between cells in the same individual. To
determine the diversity of eccDNAs in cells from the same
individual, we isolated and sequenced eccDNA from triplicate
leukocyte samples from two individuals (3 × 104) cells per sam-
ple (n= 3 for each participant, Supplementary Fig. 6) along with
a control for endonuclease digestion of mitochondrial DNA
(Supplementary Fig. 6g, h). Samples contained similar numbers
and size distributions of eccDNAs (median 2,169 ± 429 and
median 3,155 ± 453; Supplementary Fig. 7, Supplementary
Data 6). However, the genetic content of eccDNA was very dif-
ferent between leukocytes from the same individual. From the
three samples from participant 6, only 12 eccDNAs had over-
lapping sequences and only 13 from participant 14 overlapped
(Supplementary Fig. 8). We reasoned that the small overlap might
result from the constant turnover of leukocytes from the billions
of hematopoietic stem cells and myeloid/lymphoid progenitor
cells in the human body. Different DNA circularization events in
these stem cells would explain a large individual variation
between otherwise genetically identical cells.
Discussion
EccDNA has long been known to form from proto-oncogenes
and repeats in the human genome9,10,32,45,46. However, the
diversity of eccDNA identiﬁed in this study supports a model in
which any part of the human genome can contribute to eccDNA.
Our model implies that deleted DNA is not immediately lost or
degraded, but persists in the nucleus as eccDNA, formed through
various circularization paths that are likely mediated by the repair
machinery for DNA damage, such as nonhomologous end-
joining20,23,24, nonallelic homologous recombination34, or
microhomology-mediated end-joining20,23. EccDNAs are com-
mon in yeast27 and plants47,48, suggesting that the propensity for
genomes to form and retain eccDNA is conserved among
eukaryotes. Our data further reveal that large parts of the human
genome can be found on eccDNA. Although this ﬁnding suggests
that eccDNAs are formed through random mutational processes,
we also found hotspots for eccDNA formation in the human
genome. We found that gene-rich chromosomes, repetitive
sequences, and tandem paralogous genes had a higher tendency
to circularize and form eccDNA, in agreement with previous data
from human germline and yeast25,27,49,50. Recombination
between tandem paralogous sequences lead both to eccDNA and
a corresponding deletion in yeast25. We also found recurrent
eccDNA, and corresponding deletions (Fig. 4c), supporting the
hypothesis that certain loci in human somatic tissue have a high
propensity to circularize and form chromosomal deletions.
EccDNAs mapped more frequently to gene-rich chromosomes
indicating that genic regions generally mutate at higher rates.
This result supports previous ﬁndings of overrepresented 5
´UTRs, exons20 and 3´UTRs23 on eccDNA. Of particular interest
in this context is that the most highly transcribed gene, TTN
(encoding titin), also produced the highest number of eccDNAs
(n= 130, physically active group, Fig. 5). We conﬁrmed the 35.4-
kb [TTNcircle exon 43-66] and 23.9-kb [TTNcircle exon 44-52] and also
found support for [TTNcircle] transcription in ﬁve participants
(Supplementary Table 4). Titin is expressed in muscle, where it
provides elasticity in the resting state. It is the most abundant
protein in the human body with an approximate mass of 0.5 kg in
an adult human51. Loss of titin leads to myopathies52, making it
plausible that the formation of many [TTNcircles] represents a
mutational load that reﬂects high transcriptional activity of TTN
in the muscle. However, how eccDNA formation frequencies are
connected to genic DNA is still unclear. Direct repeat recombi-
nation is found to increase upon transcription53 and transcription
itself could provide the basis for DNA damage through R-loops
that consist of a DNA:RNA hybrid, exposing single-stranded
DNA. R-loops form naturally during transcription, but can have
deleterious effects on DNA integrity54, which is why they could
be a link between transcriptionally active DNA and eccDNA
formation. EccDNAs themselves were also transcribed. We found
25 transcripts across eccDNA junctions, suggesting that at least a
fraction of eccDNAs resides inside the nucleus. The number of
identiﬁed eccDNA transcripts is likely an underestimation of the
true number, because tissue for eccDNA mapping and mRNA
isolation was sampled from different sections of the same biopsies
and only eccDNA or mRNA that was present in larger parts of
the muscle would be expected to be found in both samples. Gene
products from eccDNA transcripts could potentially contribute to
the phenotype of somatic cells and tissue as reported in
yeast25,55,56, where for instance, eccDNA with an amino acid
transporter gene was selected in cells grown under amino acid
limitation25. In human cells, eccDNAs with copies of proto-
oncogenes, such as cMYC and EGFR, affect phenotypes by
inducing tumorigenesis via increased eccDNA copy numbers,
leading to elevated transcript levels10,57,58.
In the present study, nearly all eccDNAs were acentric and
could be expected to segregate nonfaithfully upon replication in
mitosis, as previously shown for double minutes in tumors45. This
phenomenon provides the basis for cell-to-cell variation in both
protein expression and protein isoforms. EccDNA might further
alter traits if they integrate back into chromosomes as reported in
tumor xenografts11, cattle26, and wine yeast59.
We detected more than a thousand different breakpoints more
than 25 kb apart. Each of these putative circular DNA structures
was detected on the basis of two independent pairs of structural-
read variants (Fig. 1c) that both supported the existence of a
potential large eccDNA. Investigation of three-dimensional con-
tact domains in the human genome supported the existence of
large loop structures from 40 kb to 3Mb (median size 185 kb),
bringing together regions that are far apart60, and, thus, making
circularization plausible. Humans can live with Mb-sized ring
chromosomes in their somatic cells15,16. In human tumors,
double minutes with proto-oncogenes are reported up to 330
kb9,46, and 28-µm-long eccDNAs (~100 kb) are reported in
mouse thymocytes61. In this study, some breakpoints >25 kb
apart were detected multiple times. However, these breakpoints
were not all supported by high internal coverage, presumably
because of low abundance and because the phi29 ampliﬁcation
step in the Circle-Seq method is biased for small and more
abundant eccDNAs62. Moreover, distant breakpoints could
resemble more complex structures, as observed for eccDNA in
tumor cells45,63,64. EccDNAs have also been shown to gradually
enlarge through assembly from smaller circular elements9,45 and
perhaps diminish in size over time through internal deletions.
Our current eccDNA mapping pipeline does not distinguish
between eccDNA derived from a single DNA or several DNA
fragments. Therefore, we cannot exclude that some detected
eccDNAs resembled complex structures.
In agreement with previous studies20,22,32, we detected abun-
dant <2 kb eccDNAs (microDNAs), most 100–200 bp. Micro-
DNAs are suggested to be products of microdeletions20 and to
form through the mismatch repair pathway21. In contrast, a
recent study implies that many of these DNA fragments are
products of apoptosis44, requiring further investigation. We
cannot rule out that some of the eccDNAs recorded in this study
were also products of apoptosis. However, our detection of
eccDNA transcripts and multiple recurrent eccDNAs in both
blood and tissue samples suggest that eccDNAs are present in
living tissue.
In summary, we conclude that eccDNAs are common in
healthy human tissue and blood in sizes large enough to carry one
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or several complete genes. We ﬁnd that eccDNAs are tran-
scriptionally active and we suggest that eccDNA contribute to
phenotypic variation through expression of full-length and/or
truncated genes. Replicating and transcribed acentric eccDNAs
are especially expected to have cellular impact, as missegregation
in mitosis is expected to yield variable eccDNA copy numbers.
Methods
Healthy human subjects. Two groups of healthy male participants, physically
inactive and physically active, were selected based on questionnaires. The inactive
group (n= 8, age 62.8 ± 1.3 years, weight 82.9 ± 14 kg) had a lifelong sedentary
lifestyle with physical activity once per week at most throughout their life. The
physically active group (n= 8, age 62.1 ± 1.4 years, weight 82.3 ± 12 kg) had
exercised more than three times per week throughout their life. Ethical approval
was granted by the Committee of Copenhagen and Frederiksberg communities,
reference number H-7-2014-001 and the research was conducted in accordance
with the guidelines of The Declaration of Helsinki. All participants gave their
written consent to take part in this study after being informed of the experimental
procedures and associated risks. Physiological measurements of percent body fat by
dual-energy X-ray absorptiometry scanning conﬁrmed group differences (30.5 ±
7.9 and 21.9 ± 4.2% in the physically inactive and active groups, respectively). An
incremental ergometer cycling challenge consisted of cycling at 120 watts for 5 min,
increasing by 20 watts every other minute to perceived exertion of 18 on the Borg
scale65, after which participants continued until exhaustion. The cycling test
showed differences in exercise performance between groups, while no signiﬁcant
differences were documented for age, height, weight, cholesterol, testosterone,
inﬂammation, and number of leukocytes (see Supplementary Table 1). Lower
protein carbonylation in skeletal muscle from active participants, measured by the
OxiSelect ELISA-kit (Cell Biolabs), conﬁrmed a signiﬁcant lower oxidative stress
level in this group compared to inactive participants (Supplementary Table 1).
Plasmids. All plasmids were maintained in Escherichia coli and puriﬁed with a
standard plasmid miniprep kit (GeneJet, Thermo Scientiﬁc). Plasmid controls were
pBR322 (4,361 bp; New England Biolabs), pUC19_yEGFP3 (3,397 bp), pUG72
(3,988 bp; originally pJJH726, EUROSCARF), pSH63 (6,998 bp), and
YGPM3k20_pGP564_chrV (26305 bp; Open Biosystems).
Human samples from healthy human muscle tissue (T1–T16). Under local
anesthesia, muscle biopsies from vastus lateralis were collected (Bergström needle),
quickly transferred into liquid nitrogen, and later stored at –80 °C. Tissues were
fractionated at −20 °C and aliquots of 50–100 mg were sliced into thin pieces with
a sterile scalpel and air-dried at room temperature for 1 h before weighing 6 mg
tissue (Extended Data Fig. 1a) on an analytical scale (Mettler Toledo). Samples
were denoted T1–T16. Odd numbers were used for tissues from the physically
inactive group and even numbers for tissues from the physically active group.
Human leukocytes (B1–B16, B6A–C, B6D; B14A–C, B14D). Blood (40 mL) was
collected from arm veins and centrifuged at 2.6× g for 15 min at 4 °C (Eppendorf
5702 R). To match cell concentrations, the middle buffy coat layer (leukocytes) was
collected and nuclei were counted (NucleoCounter NC-3000, Chemometec).
Samples of ~105 leukocytes were lysed for 10 min on ice with 1 × buffer C (Qiagen)
and 3 × volume ultraclean water and centrifuged at 1,565× g for 15 min at 4 °C.
Nuclear pellets were stored at −80 °C until eccDNA puriﬁcation. The samples were
denoted B1–B16. Triplicate aliquots were taken from blood samples of two donors
and denoted B6A–C; B14A–C, with two extra samples serving as controls to test
potential differences between endonuclease NotI (B6D and B14D) and MssI
(B6A–C; B14A–C).
Circle-Seq. Puriﬁcation of eukaryotic eccDNA from human somatic tissue was
optimized based on the Circle-Seq eccDNA method for budding yeast28, consisting
of multiple steps as described below.
Cell lysis for Circle-Seq. In brief, samples of 6 mg tissue (106 ± 3 × 105 genomes)
or leukocyte pellets (104 ± 7 × 103 genomes) were resuspended in 0.63 mL
L1 solution (Plasmid Mini AX; A&A Biotechnology) and supplemented with 15 µl
Proteinase K (>0.1 U/µl, Life Technologies) before incubation overnight at 50 °C
with agitation at 700 rpm (Eppendorf Thermomixer). After cell lysis, a control
mixture of plasmids of different sizes and concentrations was added to each
sample: 100 copies pSH63, 100 copies pUC19_yEGFP3, 10,000 copies
YGPM3k20_pGP564_chrV, 20,000 copies pBR322, and 50,000 copies pUG72. At
this point, 30 µl was sampled to assess the input DNA concentration by qPCR.
Extrachromosomal circular DNA enrichment for Circle-Seq. Samples were
alkaline treated to separate chromosomal DNA, lipids, and protein from eccDNAs
by rapid DNA denaturing–renaturing, followed by column chromatography on an
ion exchange membrane column (Plasmid Mini AX; A&A Biotechnology). DNA
precipitation was achieved by 45-min incubation at -20 °C (after column elution)
and extended centrifugation at 9,788× g for 30 min at 2 °C. Precipitated DNA was
dissolved in 50 µl water for total DNA 40–419 ng (tissue, T1–T16), 10–224 ng
(blood, B1–B16), 22–33 ng (B6A–D) and 36–53 ng (B14A–D) by Qubit dsDNA
High Sensitivity assay.
Removal of linear and mitochondrial DNA for Circle-Seq. Remaining linear
DNA was removed by exonuclease (Plasmid-Safe ATP-dependent DNase, Epi-
centre), assisted by rare-cutting endonuclease MssI that digested mitochondrial
circular DNA (mtDNA, 16 kb) and made additional accessible DNA ends for
exonuclease. DNA was treated with two FastDigest Units MssI (GTTT^AAAC)
(Thermo Scientiﬁc) and incubated at 37 °C for 16 h. The NotI (GC^GGCCGC) site
is absent in human mtDNA and NotI (Thermo Scientiﬁc) was used in B6D and
B14D blood samples to evaluate use of different endonucleases. Prior to the exo-
nuclease step, endonucleases were thermally inactivated at 65 °C for 10 min (MssI)
or at 80 °C for 5 min (NotI). Enzymatic reactions with linear-speciﬁc exonucleases
were at 37 °C in a heating block and chromosomal DNA digestion was carried out
continuously for 1 week (144 h tissue, 168 h, blood), adding additional ATP and
DNase every 24 h (30 units per day) according to the manufacturer’s protocol
(Plasmid-Safe ATP-dependent DNase, Epicentre). Finally, the exonuclease was
heat inactivated at 70 °C for 30 min. Complete removal of linear DNA was con-
ﬁrmed by qPCR of the COX5B gene.
Rolling-circle ampliﬁcation of eccDNA for Circle-Seq. Sample volumes were
reduced to 50% under vacuum for 15–20 min (MAXI dry Iyo). Approximately 10%
(10 µL) of the total volume of eccDNA-enriched samples was used as template for
phi29 polymerase reactions (REPLI-g Midi Kit) amplifying DNA at 30 °C for
2 days (46–48 h).
EccDNA sequencing from T1–16 and B1–16 for Circle-Seq. Phi29-ampliﬁed
DNA was cleaned (QIAquick kits) and sheared by sonication (Bioruptor) to
average insert sizes of 430 ± 30 nucleotides for tissue and 400 ± 25 nucleotides for
blood (Bioanalyser). Libraries were prepared by standard methods from ~200 ng
puriﬁed fragmented DNA, adding adapters and using double indexes (P5 and P7),
each with 6-base nucleotide barcodes. The 32 samples were multiplexed in four sets
of eight and each set was sequenced as 2 × 100-nucleotide paired-end reads on 2
lanes (Illumina HiSeq 2000), collecting up to 200 million paired-end reads/sample
(tissue, T1–T16; blood, B1–B16).
EccDNA sequencing from blood replicates for Circle-Seq. Each phi29-ampliﬁed
DNA sample was sheared by sonication to mean fragment size 300 nucleotides
(Covaris LE220). The DNA was puriﬁed by beads (Ampure bead) and the size
distribution of fragments was analyzed (Bioanalyzer QC). The DNA was adjusted
to 20 ng/µL, loading 300 ng fragmented DNA for each library preparation
(Wafergen’s PrepX ILM DNA Library Kit) onto a robotic Apollo 324 system
(IntegenX), adding adapters and barcode index labels (6-base oligos). Eight samples
(B6A–D, B14A–D) were multiplexed and sequenced as 2 × 75-nucleotide paired-
end reads on two lanes (Illumina HiSeq 2000 Rapid ﬂowcell) obtaining 30.5–42.5
million paired-end reads per sample for B6A–D and 39.7-50.1 million paired-end
reads per sample for B14A–D.
Deep sequencing of samples T2 and T7 for Circle-Seq. A pool of two tissue
samples (T2+ T7) was resequenced as 2 × 75-nucleotide paired-end reads on two
lanes (Illumina HiSeq 2500 Rapid) obtaining 650.4 and 255.6 million reads,
denoted T2deep and T7deep, respectively.
Uniquely mapped eccDNA pipeline for Circle-Seq data. Sequence reads were
mapped to a human reference genome to record the origin of chromosomal-
derived eccDNAs. The mapping pipeline used aligned structural-read variants to
detect eccDNAs and assigned a level of conf to each. Pipeline steps were: 1)
Multiplexed datasets were generated by splitting index barcodes, allowing zero
mismatches. 2) Adapter sequences and low-quality bases (Q < 10) were trimmed
using Cutadapt66. 3) To improve eccDNA detection, overlapping sequences in read
pairs were merged by SeqPrep (https://github.com/jstjohn/SeqPrep) with default
settings to obtain longer singleton contigs. Small eccDNAs with a fragmented DNA
insert of <400–500 bp were expected to have substantial overlap between read pairs.
4) The Burrows–Wheeler aligner with maximal exact matches (BWA-MEM)67 was
used to align paired-end reads, singleton contigs, and singleton reads (without a
mate) against the GRCh37 human reference assembly. Read alignments were
sorted and indexed using samtools68. 5) EccDNAs were detected by ﬁrst annotating
chromosomal positions with at least two overlapping structural-read variants
(i–iii), i.e., (i) discordant paired-end reads mapped to the opposite orientation
(reverse-forward) of the reference genome as opposed to normal concordant mates
(forward–reverse), yielding approximate chromosomal coordinates of candidate
eccDNAs; (ii) Soft-clipped reads had partially mapped reads (at least 50 soft-
clipped bases) at genomic coordinates of potential eccDNA junctions (starts or
ends); and (iii) Split reads had both start and end coordinates of putative eccDNA
junctions at base-pair resolution (Fig. 1c). Split reads were obtained by remapping
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03369-8 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:1069 | DOI: 10.1038/s41467-018-03369-8 |www.nature.com/naturecommunications 9
nonmapped fragments of soft-clipped reads using BWA-MEM. If read fragments
aligned in the same orientation and to the same chromosome as soft-clipped reads,
the chromosomal position was annotated. This mapping used only eccDNAs ≤1
Mb. 6) Next, read coverage of candidate eccDNA-derived regions was assessed by
listing mean coverage value with annotations of coverage of adjacent upstream and
downstream of regions in the same length as the mapped eccDNA. 7) conf levels of
eccDNA recordings were assigned as lowq if they had at least two overlapping
structural-read variants aligned to a speciﬁc genomic location, conf if they also had
read coverage of the region of more than 95% and hconf if they satisﬁed those
criteria and mean read coverage was more than twice as high as adjacent regions
with equivalent lengths (sum of coverage). 8) EccDNAs that occurred in over-
lapping regions, but had different sizes were assessed. Although such reads could
stem from the same eccDNA molecule, no merging was performed if the reciprocal
overlap was less than 50%, as the eccDNA could have derived multiple times from
the same locus in close proximity. 9) Final lists of recorded eccDNAs were com-
bined (Supplementary Figure 1, tissue 1-16; Supplementary Fig. 2, blood 1-16;
Supplementary Fig. 6, B6A–D+ B14A–D), including in all entries details of read
support, mean coverage, annotated eccDNA coordinates, and intersections of
human genes.
EccDNA detection as function of mapped reads. To verify that additional
sequencing would lead to saturation in total number of eccDNA detections, we
sequenced samples T2 and T7 in depth, obtaining 6.4 × 108 and 2.5 × 108 mapped
reads in total. Compared to all 16 samples from tissue and leukocytes (Supple-
mentary Fig. 2a-d), deeply sequenced T2 and T7 samples showed a clear tendency
to saturation after detection of additional 6,549 and 5,464 eccDNAs, respectively
(Supplementary Fig. 2e, f)
Endonuclease effects on eccDNA counts. MssI has a single site in mtDNA. To
evaluate its endonuclease speciﬁcity on triplicate blood samples (B6A–C and
B14A–C) and potential inﬂuence on eccDNA counts and sizes, blood samples from
the same donors were also treated with NotI (GC^GGCCGC, sample B6D and
B14D). MtDNA detection by Circle-Seq and by qPCR was signiﬁcantly higher in
both D samples compared to A–C samples, supporting that MssI treatment sub-
stantially reduced mtDNA abundance without major impact on eccDNA counts or
size distributions (Supplementary Fig. 6g, h).
Non-unique eccDNA. Mapping of plasmids and nonunique reads from transpo-
sons, centromeres, telomeres, rDNA, satellites, and mtDNA was assessed by
mapping all eccDNA-derived reads to a custom genome. The custom genome was
based on all consensus sequences from all repeat classes of Homo sapiens (583 loci,
Repbase, Genetic Information Research Institute) and published sequences from
telomeres, centromeres69, the complete sequence of the human rDNA repeating
unit (43 kb, locus HSU13369, accession U13369, PRI 12-MAR-2010), mtDNA
(16.57 kb, chrM_GRCh37-hg19), and spiked-in plasmids.
Quantiﬁcation of eccDNA based on internal controls. The number of eccDNAs
per nucleus was calculated based on fractions of reads mapped to 4-kb spike-in
plasmid controls (pUG72 and pBR322, Fig. 2c). Added to each muscle sample was
50,000 pUG72 and 20,000 pBR322 plasmids. Using the lowest and highest percent
read values of pUG72 (0.0015% and 0.2596%) and pBR322 (0.0002% and
0.0905%), we estimated around 1–250 eccDNAs of 4 kb per nucleus. Using percent
reads for SINE elements (1.676% and 8.432%) relative to percent reads for pUG72
or pBR322 per nucleus, we estimated [SINEcircles] of 16–1700 per nucleus with sizes
of ~400 bp. These calculations are rough estimates because rolling-circle ampliﬁ-
cation of eccDNAs with phi29 polymerase is biased toward abundant and small
eccDNAs62.
Assessment of eccDNA sequencing saturation. The number of eccDNAs per
million reads was determined at different sequence levels by decimation of read
amounts at 10% intervals to generate decimation curves (Supplementary Fig. 2).
EccDNA genomic coverage. Total coverage of eccDNAs for all samples was found
by concatenation and merging of all eccDNAs to calculate the combined length of
the genome from which the eccDNA was derived.
EccDNA per Mb relative to genomic features. The number of coding genes,
noncoding genes, pseudogenes, and short variants per chromosome was obtained
from GRCh38.p10 (Ensembl release 88 - Mar 2017 EMBL-EBI) to calculate
chromosomal features per Mb relative to the recorded number of eccDNAs per
Mb. Correlation tests were calculated using Spearman’s rank in R-studio70.
Genomic plots. All intersection operations between eccDNA intervals were set for
a reciprocal overlap of at least 90%, using Bedops71. Intersection proﬁles and
merged tracks were plotted into a genome map using a modiﬁed source code of
w4Cseq72.
Intersection with common genomic variants. Breakpoint coordinates of eccD-
NAs larger than 25 kb were intersected against the database of genomic variants42
with BedTools (v2.26.0-148-gd1953b6), using a reciprocal overlap of 99%.
Quantiﬁcation of genomes per sample. The number of genomes per sample was
quantiﬁed by qPCR at the cytochrome C oxidase subunit Vb gene locus (COX5B,
2q11.2). To estimate input DNA, 30-µl aliquots, sampled after 18 h of Proteinase K
digestion, were used as templates for qPCR after DNA cleaning (magnetic beads,
Agencourt). To estimate the remaining linear DNA, 1 week exonuclease-treated
DNA was used as template for qPCR. Oligos for qPCR at the human COX5B locus
were 5’ GGGCACCATTTTCCTTGATCAT 3’ and 5’ AGTCGCCTGCTCTT-
CATCAG 3’; at the human mtDNA Cytochrome C oxidase 1 (MT-CO1) gene locus
5’ GCCCACTTCCACTATGTCCT 3’ and 5’ GATTTTGGCGTAGGTTTGGTCT
3’. All reactions were run in quadruplicate in a Quant Studio 7 Flex qPCR machine
(Applied Biosystems) in 10-µL reactions with 2 µL template (exonuclease-treated
samples), 60 nM primers, and 5 µL SYBR Green PCR Master Mix (Applied Bio-
systems). Reaction conditions were 10 min at 95 °C followed by 40 cycles of 15 sec
at 95 °C and 60 sec at 60 °C. To verify reaction speciﬁcity, the melting curves were
generated and the length of PCR products veriﬁed by conventional agarose gel
electrophoresis. Puriﬁed human genomic DNA in eight serial dilutions was used to
produce standard curves for each run. Copy numbers were calculated, assuming
two copies of COX5B per genome, a molar mass per base pair of 650 g mol−1, a
genome length of 3.14 × 109 bp, and 6.77 × 10−3 ng DNA per diploid cell. A
minimum of two independent qPCR experiments was used for standard deviation
calculations. Concentrations of standards were measured using the Qubit dsDNA
High Sensitivity assay (Life Technologies).
Validation of eccDNA recordings. Outward directing PCR oligos were designed
in Primer3web (version 4.0) and devised to yield products across junctions of 20
detected circular DNA structures (Supplementary Table 6). Each 50-µl PCR
reaction typically included 120 ng phi29-ampliﬁed template (4 µl) or 1 week
exonuclease-treated template (4 µL), 200–320 nM primer, dNTP, buffer, and
DreamTaq polymerase, and PCR was for 35 cycles in a PCR cycler (Techne Pri-
meG) under standard PCR conditions. All reactions were performed with controls
of human genomic DNA (100–200 ng) and 120 ng from a phi29-ampliﬁed sample
lacking the eccDNA and nontemplate control. Inward designed oligos (Supple-
mentary Table 6) were positive controls for PCR reactions with circular and linear
DNA templates. Size-separation of PCR products on agarose (0.6–1.5%) gel elec-
trophoresis and Sanger sequencing of PCR products conﬁrmed the circular
structure of 17 of 20 selected eccDNAs (Fig. 3c, Supplementary Fig. 4). Three
eccDNAs missed ﬁnal Sanger sequencing validation (HDAC1, EGFR, and
SLC12A8) and had less coverage and support from structural variation reads than
other eccDNAs, indicating they might be rare. In addition to validation of 17
recorded eccDNAs, we validated mitochondrial circular DNA (16 kb) by outward
PCR as well as two internal plasmids (pBR322 and pUG72), spiked into prior
eccDNA puriﬁcations.
Recording of DAZ4 deletions. 5′ TGCCTGAAAAGAAAGGTTCCAG 3′ and 5′
GTCTTAGTGGAACCTTATCACCAG 3′ oligos were designed to detect the DAZ4
deletion in close proximity to the detected coordinates of [DAZ4circle], expecting a
310-bp deletion product when using puriﬁed genomic DNA as template from
participants with [DAZ4circle].
Whole transcriptome sequencing. For gene expression analyses, total RNA from
muscle tissue was extracted using the RNeasy Tissue Mini Kit according to the
manufacturer’s protocol (QIAGEN). RNA libraries were constructed using the
TruSeq Stranded total RNA LT Sample Prep Kit (Illumina) with 500 ng total RNA,
according to manufacturer’s instructions. RNA-seq libraries were sequenced using
the Illumina HiSeq 2000 instrument following manufacturer’s instructions.
Sequencing was up to 2 × 101 cycles. Image analyses and base callings used the
standard Illumina pipeline. The TopHat2 package73 was used to align reads to the
hg19 reference genome, followed by DESEQ2 for RNA expression analysis74.
EccDNA transcription detection. The Segemehl aligner (v0.2.0-418)75 was used in
split-read mode, without realignment, to detect RNA-sequenced split-transcript
reads, deﬁned as reads in which the left part aligned to the downstream 3’-end and
the right part to the upstream 5’-end. Aligner output was processed with custom
Python scripts. Reads aligned to the mitochondrial genome were excluded from
downstream analysis. Split-transcript read intervals (similar to “backspliced” reads
on circular RNA76) that overlapped 100% to detected eccDNA coordinates were
collected, discarding split-transcript reads with more than 20-nucleotide deviations
from chromosomal start coordinates of detected eccDNAs to eliminate false-
positives caused by transsplicing events. Hence, the recording of split-transcript
reads was highly restricted to eccDNAs detected with soft-clipped and/or split
reads.
Detected eccDNA transcripts in the RNA sequence data were ranked based on
the mapping quality of the number of RNA split-transcript reads. Hconf
transcribed eccDNA had a perfect match between start and end coordinates with a
sequence that was unique in the genome. Conf was similar to hconf, except the
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transcript sequence was not unique in the genome. Lowq transcribed eccDNA
meant the start or end eccDNA coordinate overlapped the detected transcript and
the split-read mapped to multiple positions in the genome.
Monte Carlo simulations. The likelihood of detected overlaps between RNA split-
transcripts and eccDNA coordinates was assessed by Monte Carlo simulations,
using pybedtools77. EccDNA coordinates and RNA split-transcript intervals were
randomized on the human genome 1,000 times and an empirical p-value was
computed based on the number of random intersections relative to the actual
detected overlaps between eccDNA and RNA split-transcripts.
Statistical analyses. Average and standard deviations were calculated for all data,
where Gaussian distribution could be assumed. Median values were used to
describe data relating to size, number, and content of eccDNA, as the underlying
data distribution was unknown.
Code availability. The pipeline for mapping Circle-Seq data was written in Python
and the Python package is provided on request for easy installation. It uses multiple
CPU cores to ensure fast processing and intermediate ﬁles in the pipeline are well
annotated to allow detailed analysis of the resulting output. The code is available
from Marghoob Mohiyuddin on request.
Data availability. Sequence data from Circle-Seq and RNA-Seq experiments have
been deposited in the Sequence Read Archive. BioSample accession IDs for DNA
Circle-Seq: SAMN08054900 to SAMN08054941. Bioproject ID for RNA-seq
PRJNA392413.
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